Enterome to attend upcoming conferences
Paris, France – October 4, 2021
ENTEROME SA, a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases, today announces that Pierre Belichard, CEO, will attend and take part in 1-on-1 meetings with institutional investors at the following conferences:
- BMO fall Life Sciences Private Company Showcase: October 14
- Jefferies Annual IBD Next Generation Therapeutics Summit: October 19
- Jefferies Global Healthcare Conference: November 16 -18
Download the press release (.pdf format)